A Study Evaluating the Safety and Antitumor Activity of IPI-504, in Patients With Metastatic Melanoma

NCT00627419 · clinicaltrials.gov ↗
PHASE2
Phase
TERMINATED
Status
1
Enrollment
INDUSTRY
Sponsor class

Stopped Study closed \& recruitment will not recommence

Conditions

Interventions

Sponsor

Infinity Pharmaceuticals, Inc.